Non-myeloid cells are every cell in the body that does not belong to the myeloid lineage, a family of blood cells that includes neutrophils, macrophages, red blood cells, and platelets. That makes “non-myeloid” a surprisingly broad label: it covers the entire lymphoid branch of the immune system (T cells, B cells, and natural killer cells), plus every structural and supportive cell type from the endothelial cells lining blood vessels to the fibroblasts holding tissues together. The term comes up often in lab reports, cancer research, and immunology papers, and understanding what it includes reveals how much of the body’s defense and maintenance work happens outside the myeloid compartment.
Where the Myeloid Line Ends and Everything Else Begins
All blood cells trace back to hematopoietic stem cells in the bone marrow. Early in their development, progenitor cells commit to one of two major branches: the myeloid lineage or the lymphoid lineage. Common myeloid progenitors give rise to granulocytes (the neutrophils, eosinophils, and basophils that swarm infection sites), monocytes and macrophages (which engulf debris and pathogens), megakaryocytes (which produce platelets for clotting), and erythrocytes (red blood cells that carry oxygen). Common lymphoid progenitors, meanwhile, differentiate into T cells, B cells, and natural killer cells with very little myeloid potential under normal conditions.1PubMed Central. Lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors
When researchers or clinicians say “non-myeloid,” they usually mean everything on the lymphoid side of that split. But the term can also sweep in cells that never came from the bone marrow at all: epithelial cells, fibroblasts, endothelial cells, neurons, and others. Context matters. In a blood cancer report, “non-myeloid” typically distinguishes lymphoid leukemias from myeloid ones. In tumor biology, it might refer to all the structural cells surrounding a tumor that influence how the immune system responds. In either case, the defining feature is the same: these cells are not neutrophils, not macrophages, not red blood cells, and not platelets.
T Cells and the Lymphoid Defense
T cells are the most talked-about members of the non-myeloid immune family, and for good reason. They are the adaptive immune system’s precision instruments. When a T cell’s receptor locks onto a fragment of a pathogen displayed on a cell’s surface, it triggers a cascade of molecular reprogramming that transforms the T cell into a specialized effector.2PubMed Central. Integrative temporal multi-omics reveals uncoupling of transcriptome and proteome during human T cell activation CD4 “helper” T cells coordinate the broader immune response by signaling to other cells. CD8 “cytotoxic” T cells kill infected or abnormal cells directly by punching holes in their membranes.
The specificity of T cells is what sets them apart from myeloid defenders like neutrophils. A neutrophil responds to generic danger signals and attacks more or less anything flagged as foreign. A T cell, by contrast, remembers a particular molecular signature and can mount a faster, stronger response if it encounters the same threat again. This is the basis of immunological memory and, by extension, vaccination.
B Cells and Antibody Production
B cells are the other pillar of adaptive immunity. Their defining trick is producing antibodies, Y-shaped proteins that latch onto specific targets and tag them for destruction. When a B cell is activated, it can differentiate into a plasma cell, a factory optimized for churning out antibodies. This transformation involves dramatic internal remodeling: the cell’s protein-folding machinery expands to handle the volume of antibody molecules being assembled and secreted.3PubMed Central. Regulation of B Cell Differentiation by Intracellular Membrane-Associated Proteins and microRNAs: Role in the Antibody Response
Some plasma cells are short-lived, disappearing once the immediate threat passes. Others become long-lived plasma cells that settle in the bone marrow and continue secreting antibodies for years, providing lasting protection. Research in mouse models has shown that the survival and generation of these long-lived plasma cells depend on a cellular self-cleaning process called autophagy; when that process is knocked out in B cells, antigen-specific long-lived plasma cells fail to form properly.3PubMed Central. Regulation of B Cell Differentiation by Intracellular Membrane-Associated Proteins and microRNAs: Role in the Antibody Response
B cells also function as antigen-presenting cells. In autoimmune hepatitis, for instance, memory B cells specific to a liver enzyme have been found to present that enzyme to CD4 T cells, effectively keeping self-reactive T cells active and contributing to ongoing autoimmune damage.4Journal of Clinical Investigation. Elucidating the role of autoreactive T cells and B cells in autoimmune hepatitis This dual role as both antibody producer and antigen presenter makes B cells more versatile than their textbook description suggests.
Natural Killer Cells and Innate Lymphoid Cells
Natural killer (NK) cells sit at an interesting crossroads: they are lymphocytes by lineage, meaning they come from the lymphoid branch, but they act more like innate immune cells because they do not need prior exposure to a pathogen to attack. NK cells patrol the body for cells that have stopped displaying normal surface markers. Healthy cells present molecules called MHC class I on their surface, essentially an identity badge. NK cells carry inhibitory receptors that recognize these badges. When a cell loses its MHC class I display, as often happens in virus-infected or cancerous cells, the inhibitory signal disappears and the NK cell attacks.5PubMed. Missing self recognition and self tolerance of natural killer cells In humans, the receptors responsible for this “missing-self” recognition are called killer cell immunoglobulin-like receptors, while mice use a related family called Ly49 molecules.6PubMed Central. Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo
NK cells are just one member of a broader family called innate lymphoid cells, or ILCs. Unlike T and B cells, ILCs do not rearrange antigen receptors, so they cannot target specific pathogens the way adaptive lymphocytes do. Instead, they respond to signals from damaged tissue and cytokines, helping to coordinate inflammation and tissue repair. Most ILCs are tissue-resident, meaning they develop during fetal life or infancy and settle into specific organs rather than circulating through the blood. Parabiosis experiments, in which two animals share a bloodstream, have confirmed that the vast majority of helper ILCs in adult organs are self-renewing residents rather than recent arrivals from the bone marrow.7Nature / Experimental & Molecular Medicine. Versatile roles of innate lymphoid cells at the mucosal barrier: from homeostasis to pathological inflammation A smaller fraction, roughly estimated by the proportion of precursor cells found in the lung vasculature, does migrate in from the bone marrow during adulthood.
Beyond the Immune System: Structural Non-Myeloid Cells
The term “non-myeloid” also captures a vast number of cells that have nothing to do with the bone marrow. Endothelial cells line every blood vessel and lymphatic vessel in the body. They are not passive plumbing. Endothelial cells display an array of adhesion molecules on their surface that actively control which immune cells can leave the bloodstream and enter tissues.8PubMed. Adhesion mechanisms of endothelial cells During inflammation, endothelial cells upregulate specific adhesion molecules and chemokines that guide leukocytes through the vessel wall and into the tissue where they are needed.9PubMed Central. Cell-cell interactions in synovitis. Endothelial cells and immune cell migration.
Lymphatic endothelial cells have their own specialized version of this role. During tissue inflammation, they change which adhesion molecules and chemokines they express, and this pattern differs depending on what kind of inflammation is occurring. A contact hypersensitivity reaction, for example, triggers strong upregulation of the adhesion molecule ICAM-1 in skin lymphatic endothelial cells, whereas inflammation triggered by a different stimulus produces a different pattern with almost no ICAM-1 increase. Dendritic cell migration to draining lymph nodes is heavily dependent on a chemokine receptor called CCR7, but the overall migration pattern is stimulus-specific.10PubMed. Tissue inflammation modulates gene expression of lymphatic endothelial cells and dendritic cell migration in a stimulus-dependent manner Dendritic cells also rely on a sugar-rich coating organized by a molecule called CD44 to physically dock with lymphatic vessel walls and enter the vessel lumen.11Life Science Alliance. Dendritic cell entry to lymphatic capillaries is orchestrated by CD44 and the hyaluronan glycocalyx
Fibroblasts are another major non-myeloid player. These connective tissue cells produce collagen and other structural proteins, but they also communicate actively with immune cells. In many tissues, fibroblasts secrete cytokines and chemokines that shape local immune responses. Epithelial cells, which form the barriers of the skin, gut, and airways, contribute too. Epithelial cells in tissues from the gums to the intestines produce antimicrobial peptides that control the growth of commensal bacteria and defend against infection by bacteria, fungi, and viruses.12PubMed Central. Antimicrobial peptides: Defending the mucosal epithelial barrier
The Bone Marrow Niche: Non-Myeloid Cells That Keep Blood Production Running
Hematopoietic stem cells do not float freely in the bone marrow. They depend on a physical microenvironment called the niche, which is created in part by non-myeloid cells. The niche is perivascular, located near blood vessels, and is built partly by mesenchymal stromal cells and endothelial cells, often near trabecular bone.13PubMed Central. The bone marrow niche for haematopoietic stem cells Endothelial cells and perivascular stromal cells expressing the leptin receptor produce the key factors required to maintain both stem cells and many of the restricted progenitors that will eventually mature into circulating blood cells.14PubMed Central. Niches that regulate stem cells and hematopoiesis in adult bone marrow
Without these non-myeloid support cells, blood production would fail. The stromal cells provide adhesion signals that hold stem cells in place, growth factors that prevent premature differentiation, and metabolic cues that keep the stem cell pool replenished over a lifetime. Damage to the niche, whether from chemotherapy, radiation, or aging, can impair blood cell production even when the stem cells themselves are intact.
When Structural Cells Present Antigens
Antigen presentation is usually associated with professional immune cells like dendritic cells and macrophages, both of which are myeloid. But several non-myeloid cell types can also present antigens to T cells. Endothelial cells, fibroblasts, and lymph node stromal cells are all capable of showing protein fragments to CD8 or CD4 T cells, either through cross-presentation or through MHC class II molecules.15PubMed Central. The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells The outcome of this presentation varies: it can activate T cells, suppress them, or induce tolerance depending on which cell type is doing the presenting and what the local inflammatory environment looks like.
This matters for understanding why immune responses in different tissues behave so differently. A T cell encountering its target antigen on a professional dendritic cell in a lymph node may become a powerful effector. The same T cell encountering the same antigen on a resting endothelial cell may be tolerized instead, learning to ignore the signal. The non-myeloid cells of a tissue are not passive bystanders; they actively shape whether immune responses ramp up or shut down.
Cancer-Associated Fibroblasts and Immune Evasion
One of the most active areas of non-myeloid cell research involves cancer-associated fibroblasts, or CAFs. In the tumor microenvironment, fibroblasts undergo changes that make them allies of the tumor rather than the immune system. CAFs remodel the extracellular matrix surrounding the tumor, secrete cytokines and growth factors, and release extracellular vesicles that collectively suppress T cell function and help cancer cells dodge immune surveillance.16PubMed Central. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives Multiple studies have confirmed that CAFs can directly suppress T cell anti-cancer activity through several mechanisms: remodeling the physical barrier of the matrix, promoting expression of immune checkpoint molecules, and secreting immunosuppressive signals.17PubMed Central. Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential
One particularly striking finding is that CAFs can cross-present tumor antigens to CD8 T cells and then kill those T cells rather than activate them. Research has shown that this death is mediated through two pathways: the FAS/FASL pathway and the PD-1/PD-L2 axis. CAFs expressed FASL and PD-L2 at higher levels than normal fibroblasts, and PD-L2 rather than PD-L1 was the dominant ligand engaging PD-1 on the T cells, a finding that surprised the researchers since PD-L1 gets far more attention in immunotherapy discussions.18Nature Communications. Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells By combining antigen cross-presentation with checkpoint-mediated killing, CAFs effectively delete the very T cells most capable of recognizing the tumor. This helps explain why some tumors resist immunotherapy even when plenty of T cells are present in the surrounding tissue.
Mesenchymal Stromal Cells in Therapy
The immunomodulatory abilities of non-myeloid stromal cells have attracted interest for therapeutic applications. Mesenchymal stromal cells, which are found in bone marrow and other tissues, can dampen immune responses through secreted factors. When cultured alongside T cells, they inhibit T cell proliferation through immunomodulatory cytokines. In inflamed conditions, they also influence myeloid cells: they can push dendritic cells and macrophages toward a tolerogenic state, reducing inflammation rather than amplifying it.19PubMed Central. Unraveling the Mesenchymal Stromal Cells’ Paracrine Immunomodulatory Effects
This has made mesenchymal stromal cells candidates for treating graft-versus-host disease, autoimmune conditions, and transplant rejection. Their effects are paracrine, meaning they work by secreting molecules into their surroundings rather than by direct cell contact, and the specific factors they release vary depending on the inflammatory signals they receive. This context-dependence is both a strength and a challenge for therapy: the cells naturally adapt to the environment, but that makes their behavior harder to predict and standardize in a clinical setting.
How Nerves Talk to Non-Myeloid Immune Cells
A relatively new frontier is the crosstalk between the nervous system and non-myeloid cells. Peripheral lymph nodes, long thought to be purely immune organs, turn out to be innervated by sensory neurons from the dorsal root ganglia. These nerves are physically present in the lymph node and respond to inflammatory stimuli: after exposure to bacterial components, the volume of sensory nerve fibers within a lymph node increases alongside the swelling of the node itself. Optogenetic experiments, where light is used to selectively activate these sensory neurons, showed that nerve stimulation changed gene expression in lymph node stromal cells as well as in immune cells like neutrophils and NK cells.20PubMed Central. Somatosensory and autonomic neuronal regulation of the immune response
This means the nervous system has a direct line to non-myeloid structural cells in the lymph node, and through them, an indirect influence on immune cell behavior. The implications are still being worked out, but the finding adds another layer to the question of what non-myeloid cells do. They are not just support structures or passive barriers. They integrate signals from the nervous system, from circulating cytokines, and from the tissue itself, and they relay processed instructions to immune cells. In a sense, non-myeloid stromal cells act as local switchboards, translating environmental information into immune decisions.
Mapping Non-Myeloid Populations With Single-Cell Technology
Much of what we now know about the diversity of non-myeloid cells comes from single-cell sequencing, a technology that reads the gene expression of individual cells rather than averaging across millions. A recent atlas of the human stomach, for example, profiled over 137,000 cells and sorted them into seven major lineages. The breakdown is revealing: alongside the expected T cells, B cells and plasma cells, and myeloid cells, the atlas identified distinct populations of fibroblasts (marked by collagen genes), endothelial cells (marked by blood vessel genes), epithelial cells, and mast cells.21Cell Press (Cell Reports). Stomach encyclopedia: Combined single-cell and spatial transcriptomics reveal cell diversity and homeostatic regulation of human stomach
What stands out in data like this is how many non-myeloid cells are present in a tissue that is not traditionally thought of as an immune organ. In the stomach dataset, B and plasma cells alone accounted for more than half of the cells profiled, dwarfing the myeloid population. Fibroblasts and endothelial cells, while smaller in absolute numbers, showed distinct gene expression profiles that hint at specialized roles in tissue maintenance and immune coordination. These atlases are rewriting our understanding of which cells matter in health and disease, revealing that non-myeloid populations are more abundant and more functionally diverse than older techniques could detect.
A Note on Microglia and Lineage Surprises
Not every cell fits neatly into the myeloid-versus-non-myeloid framework. Microglia, the resident immune cells of the brain, are a case in point. Unlike the brain’s other supportive cells, astrocytes and oligodendrocytes, which arise from neural tissue, microglia develop from myeloid progenitors in the embryonic yolk sac.22PubMed. The origin and cell lineage of microglia: new concepts They are technically myeloid cells living in a non-myeloid neighborhood. Once established in the brain during development, they self-renew locally and are rarely replaced by bone marrow-derived cells under normal conditions. This means that when brain researchers talk about “non-myeloid” cells in the central nervous system, they typically mean neurons, astrocytes, and oligodendrocytes, while microglia are the resident myeloid exception.
Evolutionary biology offers another perspective on the myeloid/non-myeloid split. Studies of jawless vertebrates like lampreys suggest that the lymphoid lineages, which in our bodies give rise to T and B cells, existed before the emergence of the antigen receptors that define those cells in modern jawed vertebrates. Lampreys have variable lymphocyte receptors that map onto separate lineages resembling the T cell and B cell branches, implying that the basic division of labor between myeloid and lymphoid compartments is ancient, predating the sophisticated adaptive immune system we carry.23PubMed Central. Reevaluation of the Immunological Big Bang: comparisons of two vertebrate adaptive immune systems The non-myeloid lineage, in other words, is not a leftover category. It is one of the oldest organizational principles in vertebrate biology.